By Adam Bonislawski
Name: Mark MolloyPosition: Director, Australian Proteome Analysis Facility; Associate Professor at Macquarie UniversityBackground: Senior Research Scientist, Discovery Proteomics at Merck; PhD Biochemistry, Macquarie University
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now. Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
The term 'epigenetics' is being used by quacks to give them a veneer of science, writes Adam Rutherford at the Observer.
The NIH has issued a preliminary guidance for newborn dried blood spot research.
Wired writes that CRISPR could change the world — in many imaginative ways — and whether it will be for the better is still in the air.
In PLOS this week: locus linked to non-syndromic hearing loss, phylogenetic relationships of Klebsiella pneumoniae isolates, and more.